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(12.2% vs. 6.2%, p¼0.003) and at one year (26.1% vs. 20.1%, p¼0.046).
Mortality was lower in patients that were additionally treated with
MitraClip system for concomitant moderate to severe MR.
CONCLUSIONS Pre-existing moderate or severe mitral regurgitation
is associated with an 97 % higher mortality at 30 days and 30 % higher
mortality at one year as compared to patients with no or mild MR.
Larger outcome studies are necessary to investigate whether addi-
tional treatment of MR in patients with concomitant moderate to se-
vere MR will improve the prognosis in a TAVR population.
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BACKGROUND Risk of stroke after TAVR is a persistent concern;
identiﬁcation of stroke predictors would be of use in patient selection.
METHODS We examined the frequency and predictors of stroke
among patients in the 2 CoreValve US Pivotal IDE trials and 2
Continued Access studies. Patients were followed prospectively. All
patients underwent physical exam and evaluation with the NIHSS at
baseline, 24 h, hospital discharge, 30 d, and 1 y postprocedure.
Neurologic events lasting >24 h or with concordant imaging abnor-
malities were classiﬁed as strokes. Modiﬁed Rankin Scale >2 deﬁned
major stroke. All rates are K-M estimates. Instantaneous stroke hazard
was modeled with the Epanetchnikov kernel-smoothing function at a
bandwidth ¼ 10 points. Three predictive models were constructed
using Cox Proportional Hazard functions (clinical parameters alone;
clinical and imaging characteristics; clinical, imaging, and procedural
characteristics).
RESULTS 3687 patients (3581 person-y) were included. Stroke
occurred <30 d in 174 (4.8%) and <1 y in 270 (8.4%); major stroke
occurred in 2.8% and 5.0%, respectively. All-cause mortality at 1 y was
45.1% for stroke patients and 63.2% for major stroke patients.
Instantaneous hazard analysis showed an early inﬂection point at 10
d (Fig); 147 (4.1%) strokes occurred in this period. Clinical predictors
of early stroke were total NIHSS >0 (HR¼1.50), PVD (HR¼1.44), prior
TIA (HR¼2.48), no prior CABG (HR¼1.72), angina (HR¼1.64), BMI<21
kg/m2 (HR¼2.14), and falls <6 mo (HR¼1.73). Addition of imaging
parameters did not change clinical predictors, but further addition of
procedural parameters added predictors: rapid pacing during valvu-
loplasty (HR¼9.9), total procedure time (HR¼1.003), and total time
delivery catheter in body (HR¼1.011). Postimplant balloon dilation did
not increase early stroke risk; non-iliofemoral access was of marginal
signiﬁcance (HR¼0.668, P¼0.058).CONCLUSIONS In this ﬁrst prospective examination of stroke after
TAVR within a series of large trials, we observed a biphasic frequency
of stroke with an early hazard occurring <10 d. Clinical predictors
were largely indicators of prior atherosclerotic vascular disease and
frailty indices. Readily available imaging parameters contributed lit-
tle, and procedural parameters reﬂected the complexity of the pro-
cedure. Further reﬁnement of imaging techniques may be of help in
future prediction of early stroke.
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BACKGROUND Transcatheter aortic valve implantation (TAVI) has
been worldwide adopted but there are still multiple areas where
consensus and evidence are lacking. Different approaches, techniques
and imaging tools are actually implemented during the procedure
with several differences according to local clinical practice. The ob-
jectives were to determine the real life practice related to procedural
techniques used during TAVI across different centers around the
world.
METHODS From January to May 2015, an online survey was distrib-
uted worldwide in centers performing TAVI regardless the number of
procedures and valve type. There was a responsible to distribute the
survey for each country or region.
RESULTS A total of 167 centers (including 37843 TAVI procedures)
responded the questionnaire from 27 different countries in Europe,
